Biomatics Capital
Biomatics Capital is a for-profit venture firm investing in transformational data-enabled innovation at the intersection of healthcare and technology. They focus on big ideas and support entrepreneurs with a network of experts. Biomatics Capital aims to create the next generation of companies transforming healthcare.
📥 Buy Full VC Dataset
Offices: Seattle (United States)
Investment Stages: Series A, Series B
Markets: Digital Health, Gene Editing, Medical Technology, Proteomics
Founded Year: 2016
Investor Type: Venture Capital
Portfolio Companies: Editas Medicine, Encodia, Omniome, Cytrellis, Verve, BEAM, EXAS, NEUMORA, ILMN, PACB
Website: https://biomaticscapital.com
Team Page: https://biomaticscapital.com/team/
Portfolio Link: https://biomaticscapital.com/portfolio/
LinkedIn: https://www.linkedin.com/company/biomatics-capital
Crunchbase: https://www.crunchbase.com/organization/biomatics-capital-partners
Pitchbook: https://pitchbook.com/profiles/investor/151204-33
Comments
No comments yet. Be the first to comment!